Hyperimmune Colostrum and Oral Mucositis

Not Applicable

• Conditions: Head and Neck Cancer

• Registration Number: NCT00699569
• Lead Sponsor: Tel-Aviv Sourasky Medical Center

Brief Summary

To study the effect of daily intake of hyperimmune colostrum on prevention and treatment of oral mucositis in patients with head and neck cancer undergoing high-dose radiation.

Detailed Description

Not available

Study Timeline

• Status Verified: 2008-06
• Study First Submitted: 2008-06-17
• Study First Submitted QC: 2008-06-17
• Study First Posted: 2008-06-18
• Study Start: 2008-07
• Last Update Submitted: 2008-07-22
• Last Update Posted: 2008-07-23
• Primary Completion: 2009-07
• Study Completion: 2009-07

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

• Patients with: naso-pharynx, oral cavity, oro-pharynx and advanced localized laryngeal cancer.

Exclusion Criteria

• Other tumors
• Non-epithelial tumors
• Pregnancy
• Poor functional status

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Trial Locations

Locations (1)

Sourasky Medical Center; 🇮🇱 Tel-Aviv, Israel